Eli Lilly Shares Are Trading Lower. The Company Announced Topline Results From the QWINT-1 and QWINT-3 Phase 3 Clinical Trials Evaluating Once Weekly Insulin Efsitora Alfa in Adults With Type 2 Diabetes Using Basal Insulin for the First Time and in...
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.